These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4094431)

  • 1. Estrogen induced expansion of the growth fraction in receptor negative human breast cancer.
    Conte PF; Fraschini G; Drewinko B
    J Steroid Biochem; 1985 Dec; 23(6B):1169-72. PubMed ID: 4094431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokinetic parameters of locally advanced human breast cancer treated with diethylstilbestrol and chemotherapy.
    Conte PF; Alama A; Di Marco E; Canavese G; Rosso R; Nicolin A
    Basic Appl Histochem; 1986; 30(2):227-31. PubMed ID: 3755591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy following estrogen-induced expansion of the growth fraction of human breast cancer.
    Conte PF; Fraschini G; Alama A; Nicolin A; Corsaro E; Canavese G; Rosso R; Drewinko B
    Cancer Res; 1985 Nov; 45(11 Pt 2):5926-30. PubMed ID: 4053064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: clinical and cytokinetic results.
    Conte PF; Alama A; Bertelli G; Canavese G; Carnino F; Catturich A; Di Marco E; Gardin G; Jacomuzzi A; Monzeglio C
    Int J Cancer; 1987 Oct; 40(4):490-4. PubMed ID: 3666987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trial.
    Conte PF; Pronzato P; Rubagotti A; Alama A; Amadori D; Demicheli R; Gardin G; Gentilini P; Jacomuzzi A; Lionetto R
    J Clin Oncol; 1987 Mar; 5(3):339-47. PubMed ID: 3546611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative activity of human solid tumors evaluated by thymidine labeling index and primer-dependent alpha-DNA polymerase.
    Alama A; Conte PF; Di Marco E; Favoni RE; Nicolin A
    Oncology; 1986; 43(6):385-9. PubMed ID: 3808572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer.
    Ingle JN; Foley JF; Mailliard JA; Krook JE; Hartmann LC; Jung SH; Veeder MH; Gesme DH; Hatfield AK; Goldberg RM
    Cancer; 1994 May; 73(9):2337-43. PubMed ID: 8168039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing the response rate to cytotoxic chemotherapy by endocrine means.
    Lippman ME; Cassidy J; Wesley M; Young RC
    J Steroid Biochem; 1985 Dec; 23(6B):1173-80. PubMed ID: 3005774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rational combinations of hormonal and cytostatic agents in disseminated forms of breast cancer].
    Garin AM; Dmitrieva NV; Vyshinskaia GV; Lichintser MR
    Vopr Onkol; 1987; 33(11):13-7. PubMed ID: 3686916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer.
    Coskun U; Gunel N; Onuk E; Yilmaz E; Bayram O; Yamac D; Cihan A; Ucan B; Yildirim Y; Celenkoglu G; Ozkan S
    Neoplasma; 2003; 50(3):210-6. PubMed ID: 12937855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo manipulation of human breast cancer growth by estrogens and growth hormone: kinetic and clinical results.
    Conte PF; Gardin G; Pronzato P; Miglietta L; Rosso R; Amadori D; Gentilini P; Monzeglio C; Gallotti P; Demicheli R
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1103-8. PubMed ID: 1981014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers.
    Collecchi P; Baldini E; Giannessi P; Naccarato AG; Passoni A; Gardin G; Roncella M; Evangelista G; Bevilacqua G; Conte PF
    Eur J Cancer; 1998 Oct; 34(11):1701-4. PubMed ID: 9893655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology Association.
    Muss HB; Richards F; Jackson DV; Cooper MR; White DR; Stuart JJ; Ramseur W; Christian RM; Wells HB; Pope E; Spurr CL
    Cancer; 1982 Dec; 50(11):2269-74. PubMed ID: 6754062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial.
    ; Ambrosini G; Balli M; Garusi G; Demicheli R; Jirillo A; Bonciarelli G; Bruscagnin G; Fila G; Bumma C; Lacroix F; Buzzi F; Di Costanzo F; Padalino D; Brugia M; Calabresi F; Natali M; Cartei G; Chiesa G; Blasina B; Ciambellotti E; Moro G; D'Aquino S; Altavilla G; Adamo V; De Maria D; Falchi AM; Bertoncelli P; Farris A; Fiorentino M; Fornasiero A; Fosser V; Daniele O; Foggi CM; Speranza GB; Sartori S; Camilluzzi E; Gallo L; Poggio R; Secondo V; Gambi A; Grignani F; Capodicasa E; Lopez M; Papaldo P; Di Lauro L; Vici P; Marenco G; Folco U; Bonanni F; Marsilio P; Palazzotto G; Di Carlo A; Cusimano MP; Pastorino G; Puccetti C; Giusto M; Rausa L; Gebbia N; Palmeri S; D'Alessandro N; Saccani F; Becchi G; Schieppati G; Spinelli I; Tagliagambe A; Tonato M; Minotti V; Ardia A; Viaro D; De Micheli P; Zingali G; Sacchetti G; Intini C
    J Clin Oncol; 1988 Jun; 6(6):976-82. PubMed ID: 2897433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR; Sutherland RL
    Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in biological markers after primary chemotherapy for breast cancers.
    Daidone MG; Silvestrini R; Luisi A; Mastore M; Benini E; Veneroni S; Brambilla C; Ferrari L; Greco M; Andreola S
    Int J Cancer; 1995 May; 61(3):301-5. PubMed ID: 7729938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.
    Meyer JS; Rao BR; Stevens SC; White WL
    Cancer; 1977 Nov; 40(5):2290-8. PubMed ID: 922670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer.
    Holmes FA; Yap HY; Esparza L; Buzdar AU; Hortobagyi GN; Blumenschein GR
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):28-31. PubMed ID: 6385262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancer.
    Mortimer J; Livingston RB; Hardesty IJ; Groppe CW; Purvis JD; Gupta M; Flournoy N
    Cancer Treat Rep; 1984; 68(7-8):1017-8. PubMed ID: 6744334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro analysis of the cellular proliferative response to 17-beta-estradiol of human breast cancer.
    Podhajcer OL; Bravo AI; Dain L; Guman N; Bover L; Mordoh J
    Cancer; 1988 May; 61(9):1807-12. PubMed ID: 3281743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.